Bio-Techne Corporation
TECH
$72.25
-$0.06-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.00% | 34.30% | -0.46% | 316.00% | -178.26% |
| Total Depreciation and Amortization | -156.51% | -2.19% | 1.52% | 244.12% | -161.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.51% | -12.75% | 125.57% | -88.23% | 1,847.77% |
| Change in Net Operating Assets | 192.55% | -322.40% | 104.32% | -298.65% | 272.71% |
| Cash from Operations | 10.10% | 5.16% | 198.75% | -71.91% | 138.82% |
| Capital Expenditure | 6.67% | -53.45% | -10.40% | -9.67% | 51.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 601.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.47% | -- | -100.00% | -70.87% | 271.04% |
| Cash from Investing | -21.32% | 1.76% | -1,078.68% | 49.01% | 104.58% |
| Total Debt Issued | -- | -- | -- | -- | 73.68% |
| Total Debt Repaid | 100.00% | -50.00% | 13.04% | 8.00% | -525.00% |
| Issuance of Common Stock | -25.15% | 532.18% | -79.83% | 277.37% | -58.14% |
| Repurchase of Common Stock | -27,383.44% | 87.49% | 86.44% | 90.77% | 0.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.27% | -0.38% | -0.21% | -0.46% | 1.53% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.26% | 12.80% | -10.82% | 51.13% | -32.93% |
| Foreign Exchange rate Adjustments | 78.28% | -387.65% | 134.13% | -109.06% | 1,335.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.60% | 32.32% | 262.08% | -180.05% | 158.34% |